Search for Clinical Trial Results
Camurati-Engelmann Disease - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer Condition: Prostate Cancer Date: 2015-05-20 Interventions:
|
Completed |
Study Name: Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma Condition: Asthma Date: 2007-09-27 Interventions: Drug: montelukast montelukast 5-mg chewable tablet with matching placebo once daily in the evening at be |
Active, not recruiting |
Study Name: Autologous/Allogeneic TGFbeta-resistant LMP2A-specific CTL, Lymphoma (TGF-beta) Condition:
Date: 2010-10-19 |
Completed |
Study Name: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma Condition:
Date: 2007-02-05 Interventions:
|
Terminated |
Study Name: Anti-TGF-beta Therapy in Patients With Myelofibrosis Condition:
|
Recruiting |
Study Name: SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer Condition:
Date: 2015-10-16 Interventions:
|
Completed |
Study Name: Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer Condition:
Date: 2009-05-09 Interventions: |
Completed |
Study Name: Fresolimumab In Systemic Sclerosis Condition: Diffuse Systemic Sclerosis Date: 2011-01-25 Interventions: Drug: Fresolimumab intravenous fresolimumab 1mg/kg, first 8 patients; 5 mg/kg following 8 patients |
Not yet recruiting |
Study Name: ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer Condition: Rectal Adenocarcinoma Date: 2016-01-25 Interventions:
|